Telitacicept Shows Durable Symptom Relief in Myasthenia Gravis Trial
Clinical trial results indicate that over 94 percent of participants achieved significant and lasting symptom improvement in generalized myasthenia gravis
Clinical trial results indicate that over 94 percent of participants achieved significant and lasting symptom improvement in generalized myasthenia gravis